Pharmascience Inc is proud to announce that it has acquired Uman Pharma Inc. on November 13, 2014.
Pharmascience's Global Injectables Division's development pipeline is focused primarily on two niche areas in oncology:
Our portfolio is mainly injectable products which meet specifications laid down by USP and BP. All products are manufactured under strict cGMP standards.
In building its portfolio, Pharmascience's Global Injectables Division focuses on products expected to create economic value and that will benefit patients and health professionals.